Ad is loading...
FSMAX
Price
$97.47
Change
+$1.63 (+1.70%)
Updated
Nov 22 closing price
VLIFX
Price
$37.03
Change
+$0.30 (+0.82%)
Updated
Nov 22 closing price
Ad is loading...

FSMAX vs VLIFX

Header iconFSMAX vs VLIFX Comparison
Open Charts FSMAX vs VLIFXBanner chart's image
Fidelity Extended Market Index
Price$97.47
Change+$1.63 (+1.70%)
VolumeN/A
CapitalizationN/A
Value Line Mid Cap Focused
Price$37.03
Change+$0.30 (+0.82%)
VolumeN/A
CapitalizationN/A
FSMAX vs VLIFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSMAX vs. VLIFX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a Buy and VLIFX is a Buy.

FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 40B vs. VLIFX (2.02B). FSMAX pays higher dividends than VLIFX: FSMAX (1.10) vs VLIFX (0.03). FSMAX was incepted earlier than VLIFX: FSMAX (13 years) vs VLIFX (75 years). FSMAX is a more actively managed with annual turnover of: 18.00 vs. VLIFX (1.00). FSMAX has a lower initial minimum investment than VLIFX: FSMAX (0) vs VLIFX (1000). FSMAX annual gain was more profitable for investors over the last year : 40.44 vs. VLIFX (21.30). FSMAX return over 5 years is better than : 59.28 vs. VLIFX (44.79).
FSMAXVLIFXFSMAX / VLIFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years75 years-
Gain YTD24.86513.927179%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets40B2.02B1,983%
Annual Yield % from dividends1.100.034,301%
Returns for 1 year40.4421.30190%
Returns for 3 years10.1111.2690%
Returns for 5 years59.2844.79132%
Returns for 10 years88.82150.7659%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LOOP1.410.09
+6.82%
Loop Industries
CDLX3.930.13
+3.42%
Cardlytics
KNSL498.698.77
+1.79%
Kinsale Capital Group
HOTH0.840.01
+1.11%
Hoth Therapeutics
ARCB109.910.91
+0.83%
ArcBest Corp